Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005
- PMID: 16882789
- DOI: 10.1542/peds.2006-0858
Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005
Abstract
From 2003 to 2005, deaths of 3 individuals as a result of cardiac arrest caused by hypocalcemia during chelation therapy were reported to the Centers for Disease Control and Prevention. Two were children, both of whom were treated with edetate disodium. At the time of this writing, the adult case was still under investigation. No previous cases of death resulting from hypocalcemia during chelation have been reported. From our experience and review of the literature, we suggest that health care providers who are unfamiliar with chelation consult an expert before undertaking treatment and that hospital formularies evaluate whether stocking edetate disodium is necessary, given the risk for hypocalcemia and the availability of less toxic alternatives.
Similar articles
-
Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003-2005.MMWR Morb Mortal Wkly Rep. 2006 Mar 3;55(8):204-7. MMWR Morb Mortal Wkly Rep. 2006. PMID: 16511441
-
Pediatric fatality secondary to EDTA chelation.Clin Toxicol (Phila). 2008 Dec;46(10):1083-4. doi: 10.1080/15563650701261488. Clin Toxicol (Phila). 2008. PMID: 18949650
-
In pediatric fatality, edetate disodium was no accident.Clin Toxicol (Phila). 2009 Mar;47(3):256; author reply 256-7. doi: 10.1080/15563650802701937. Clin Toxicol (Phila). 2009. PMID: 19274502 No abstract available.
-
A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.Clin Toxicol (Phila). 2009 Nov;47(9):841-58. doi: 10.3109/15563650903321064. Clin Toxicol (Phila). 2009. PMID: 19852620 Review.
-
Chelation therapy to treat lead toxicity in children.Minn Med. 1992 Nov;75(11):25-7. Minn Med. 1992. PMID: 1331737 Review.
Cited by
-
A Case of Severe Lead Encephalopathy with Cardiac Arrest Managed During a Chelation Shortage.J Med Toxicol. 2024 Jan;20(1):49-53. doi: 10.1007/s13181-023-00970-2. Epub 2023 Oct 16. J Med Toxicol. 2024. PMID: 37843802 Free PMC article.
-
Commentary on the abuse of metal chelation therapy in patients with autism spectrum disorders.J Med Toxicol. 2013 Dec;9(4):370-2. doi: 10.1007/s13181-013-0345-4. J Med Toxicol. 2013. PMID: 24113859 Free PMC article.
-
Towards a custom chelator for mercury: evaluation of coordination environments by molecular modeling.J Biol Inorg Chem. 2011 Jan;16(1):15-24. doi: 10.1007/s00775-010-0695-1. Epub 2010 Aug 26. J Biol Inorg Chem. 2011. PMID: 20740295
-
The Brain-Gut-Microbiome Axis: What Role Does It Play in Autism Spectrum Disorder?Curr Dev Disord Rep. 2016 Mar;3(1):75-81. doi: 10.1007/s40474-016-0077-7. Epub 2016 Feb 26. Curr Dev Disord Rep. 2016. PMID: 27398286 Free PMC article.
-
ACMT Recommends Against Use of Post-Chelator Challenge Urinary Metal Testing.J Med Toxicol. 2017 Dec;13(4):352-354. doi: 10.1007/s13181-017-0624-6. Epub 2017 Jul 19. J Med Toxicol. 2017. PMID: 28726084 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical